We read with interest 2 recent reports published in Circulation. We believe that the work of Qian et al 1 and Ridker et al 2 has an important connection in light of our recent findings. 3 Qian and coworkers 1 showed that in cholesterol-fed rabbits, increased nitric oxide production, via nitric oxide synthase gene transfer, produced rapid amelioration of several markers of atherosclerosis. Ridker et al 2 reported that pravastatin reduced levels of C-reactive protein, a sensitive marker identifying those at risk of future atherosclerotic cardiovascular events. 4,5 Furthermore, this effect was not related to the magnitude of lipid alterations.
